Literature DB >> 11163237

Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage.

E Passegué1, W Jochum, M Schorpp-Kistner, U Möhle-Steinlein, E F Wagner.   

Abstract

The functions of JunB during myelopoiesis were studied in vivo. Transgenic mice specifically lacking JunB expression in the myeloid lineage (junB(-/-)Ubi-junB mice) develop a transplantable myeloproliferative disease eventually progressing to blast crisis, which resembles human chronic myeloid leukemia. Similarly, mice reconstituted with ES cell-derived junB-/- fetal liver cells also develop a myeloproliferative disease. In both cases, the absence of JunB expression results in increased numbers of granulocyte progenitors, which display enhanced GM-CSF-mediated proliferation and extended survival, associated with changes in the expression levels of the GM-CSFalpha receptor, the anti-apoptotic proteins Bcl2 and Bclx, and the cell cycle regulators p16(INK4a) and c-Jun. Importantly, ectopic expression of JunB fully reverts the immature and hyperproliferative phenotype of JunB-deficient myeloid cells. These results identify JunB as a key transcriptional regulator of myelopoiesis and a potential tumor suppressor gene.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11163237     DOI: 10.1016/s0092-8674(01)00188-x

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  69 in total

Review 1.  Transcriptional regulation of myelopoiesis.

Authors:  Alan D Friedman
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

2.  JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction.

Authors:  Yan-Fen Hu; Rong Li
Journal:  Genes Dev       Date:  2002-06-15       Impact factor: 11.361

3.  Negative and positive regulation of gene expression by mouse histone deacetylase 1.

Authors:  Gordin Zupkovitz; Julia Tischler; Markus Posch; Iwona Sadzak; Katrin Ramsauer; Gerda Egger; Reinhard Grausenburger; Norbert Schweifer; Susanna Chiocca; Thomas Decker; Christian Seiser
Journal:  Mol Cell Biol       Date:  2006-08-28       Impact factor: 4.272

4.  Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells.

Authors:  H Jeffrey Lawrence; Julie Christensen; Stephen Fong; Yu-Long Hu; Irving Weissman; Guy Sauvageau; R Keith Humphries; Corey Largman
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

5.  Evaluation of cancer-preventive activity and structure-activity relationships of 3-demethylubiquinone Q2, isolated from the ascidian Aplidium glabrum, and its synthetic analogs.

Authors:  Sergey N Fedorov; Oleg S Radchenko; Larisa K Shubina; Nadezhda N Balaneva; Ann M Bode; Valentin A Stonik; Zigang Dong
Journal:  Pharm Res       Date:  2006-12-05       Impact factor: 4.200

6.  Fank1 interacts with Jab1 and regulates cell apoptosis via the AP-1 pathway.

Authors:  Hailong Wang; Wei Song; Tinghui Hu; Ning Zhang; Shiying Miao; Shudong Zong; Linfang Wang
Journal:  Cell Mol Life Sci       Date:  2010-10-27       Impact factor: 9.261

7.  Critical role for NF-kappaB-induced JunB in VEGF regulation and tumor angiogenesis.

Authors:  Dirk Schmidt; Björn Textor; Oliver T Pein; Alexander H Licht; Sven Andrecht; Melanie Sator-Schmitt; Norbert E Fusenig; Peter Angel; Marina Schorpp-Kistner
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

8.  JunB breakdown in mid-/late G2 is required for down-regulation of cyclin A2 levels and proper mitosis.

Authors:  Rosa Farràs; Véronique Baldin; Sandra Gallach; Claire Acquaviva; Guillaume Bossis; Isabelle Jariel-Encontre; Marc Piechaczyk
Journal:  Mol Cell Biol       Date:  2008-04-07       Impact factor: 4.272

Review 9.  Minireview: Nuclear receptors, hematopoiesis, and stem cells.

Authors:  John P Chute; Joel R Ross; Donald P McDonnell
Journal:  Mol Endocrinol       Date:  2009-11-24

Review 10.  Molecular biology of bcr-abl1-positive chronic myeloid leukemia.

Authors:  Alfonso Quintás-Cardama; Jorge Cortes
Journal:  Blood       Date:  2008-09-30       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.